Image source: Getty Images.
There’s no more promising area in cancer research right now than CAR-T immune therapies. Desperately ill cancer patients — many with no other options — are benefiting from these powerful cellular therapies that harness the power of the body’s own immune system to fight the disease. The near-miraculous treatments have shown a 70%-80% rate of total remissions, but they still come with great risk.